By
Drug Target Review2024-03-25T12:00:16
Whole genome sequencing identified 17 significant variants associated with AD risk in five genomic regions.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-25T07:00:00Z
Contributor Professor Neville Sanjana
2024-01-19T07:40:55
Sponsored by Euretos
2023-09-27T13:56:39
Sponsored by Euretos
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
Site powered by Webvision Cloud